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ABSTRACT 
Partial molar volume, V
0, of Ciprofloxacin in water, 0.05 mol Kg
-1 hydrochloric acid and 0.05 mol Kg
-1, Iron (III) chloride 
solutions at 298.15 and 308.15 K was calculated from precision densities obtained from Density Sound Analyzer (DSA 5000). 
The  data represent  the  smaller  volume  of  drug  in  0.05 mol  Kg
-1  Iron  (III)  chloride solution  than  water  and  0.05  mol  Kg
-1 
hydrochloric  acid  at  constant  temperature.    The  differences  in  volumes  are  interpreted  as  due  to  hydrophobicity  of  solutes. 
Relative hydrophobicities were estimated from volumes of transfer from one media to another media. The hydrophobicity of this 
compound also plays a key role in the drug action. The possible mechanism of drug binding with the membrane structure is also 
discussed. 
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1. INTODUCTION  
In  bio-physical  chemistry,  drug  interaction  is  the  subject  of  intensive  studies,  involving  complex  molecular 
mechanism and certain hormones, antibiotic and peptide actions, amphiphilicity in molecular structure are considered 
to be a key factor in the overall drug mechanism
1, 2. The knowledge of thermodynamic properties and properties of 
water and aqueous solutions in relations to ions or other types of solute molecules are of particular importance in 
biology
3. The partial molar volume of a solute can be regarded as the sum of intrinsic volume, Vi, plus volumetric 
effects  of  solute-solvent  interactions
4.  The  partial  molar  volume  and  the  related  volumetric  parameters  of  drug 
compounds in aqueous solutions at different temperatures and pressures have been investigated by several authors
5-9. 
Since volume is an additive property therefore gross changes in the volume of a system can be assessed by 
comparing the volume of the system with those of its components hence volumetric data of drugs can provide clues to 
the interactions occurring in cellular fluids. Recent literature on the volumetric properties of drug and other materials 
of biological importance shows increasing interest by a number of workers in this area of study (6-10). 
The  fluoroquinolones  are  well-established  broad-spectrum  antibiotics  with  activity  against  clinically 
important uropathogens
10-13. Ciprofloxacin is one of them which have been evaluated as single agents for the treatment 
of pneumonia. This fluorinated quinolone demonstrates excellent in vitro activity against Haemophilus influenzae, 
Enterobacteriacae, including Enterobacter cloacae, methicillin-susceptible Staphylococcus aureus, and Pseudomonas 
aeruginosa, and moderate activity against Streptococcus pneumoniae
14-18. Due to importance of ciprofloxacin as an 
antibiotic drug, the study of its volumetric properties in various aqueous solutions may be helpful in investigating the 
molecular phenomenon occurring in physiological media
18-22.  
This  work  is  part  of  a  study  of  molecular interactions  in  drug-substrate  systems  using  thermodynamic 
methods. Partial molar volumes of ciprofloxacin, is calculated from experimental densities in water, 0.05 mol Kg
-1 
hydrochloric acid and 0.05 mol Kg
-1,  Iron (III) chloride solutions at 298.15 and 308.15 K calculated from precision 
densities obtained from Density Sound Analyzer (DSA 5000).  The data are discussed in terms of relative solvation of 
this compound in water, hydrochloric acid and Iron (III) chloride solutions. The hydrophobicity of drug and aspects of 
structural features along with drug action are also discussed.   
 
2. EXPERIMENTAL 
Ciprofloxacin C17H18FN3O3, used in this study was supplied by Sigma (64K-661214). It is a faintly yellowish to light 
yellow crystalline substance and its chemical structure (Fig-1) The solvents used were water, conc. HCl (Riedel-231-
595-7) and FeCl3.6H2O (Merck, D6100). This compound was further purified by recrystallising from ethanol-water 
mixture. Water used in the experiments were doubly distilled and degassed. Solutions were prepared immediately 
prior to measurements by addition of stochiometric quantity ciprofloxacin to the solvents and were prepared by weight 
using Sartorious balance. The molality range studied was between 2.0 x 10
-2 ± 10
-5 mol Kg
-1 and  3.0 x 10
-2 ± 10
-5 mol 
Kg
-1. The density of Ciprofloxacin solutions of different concentrations at different temperatures were determined by 
DSA. Before measurements the DSA was calibrated using ultra pure water and air at each temperature.  
 
3. RESULTS AND DISCUSSION 
The apparent molar volumes of ciprofloxacin (V/cm
3.mol
-1) have been calculated by the following equation 
V = M/d – 10
3(d – do)/mdsdo ,                 (1) Pakistan Journal of Chemistry 2011 
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Where M is the molar mass of ciprofloxacin and do, ds and m are the solvent density, solution density and the solution 
molality, respectively. The constant 10
3 is for recalculation of molality from mol/Kg into mol/g to be consistent with 
M in mol/g. The V data obtained from equation (1) was fitted to the following equation
23. 
V = V
0 + Svm,                      (2) 
Where V
0 is the partial molar volume at infinite dilution, m is the molality of ciprofloxacin solution and Sv is the 
impirical parameter which depends on solvent, solute and temperature 
23. The values of V
0 and Sv are given in Table 1. 
The values of partial molar expansivity were then calculated from the partial molar volume by the relation: 
E
0 = (V
o/T)p                                      (3) 
The isobaric coefficient of thermal expansion was determined, as defined by
23 
()p = (E
o / V
o)p,                   (4)
 
The values of E
0 and ()p are given in Table 2. 
The increase in partial molar volume V
0 with an increase in temperature  (Table 1) is believed to be occurring due to 
the reduction in electrostriction. A decreasing trend is also observed in the values of V
0 as the solvent media changes 
from water to 0.05 mol/Kg HCl and 0.05 mol/Kg FeCl3.6H2O solution at the same temperature. This can be explained 
by the disruption phenomenon of side-group hydration by that of the charged end. The values of the partial molar 
transfer volume Vtr of ciprofloxacin in water and 0.05 mol/Kg HCl and water and 0.05 mol/Kg FeCl3 solution are 
given in Table 3 and are calculated as; 
Vtr = V
o (in water) - V
o (in aq. HCl)    (5) 
Vtr = V
o (in water) - V
o (in aq. FeCl3)    (6) 
The positive values of Vtr   indicated that he hydration shell of the solute molecule increases in volume with the 
change of solvent due to increase in hydrogen bonding with the water molecules as discussed above. This leads to 
decrease  to structure  breaking  tendency  of the ion and  then  enhance  the  electrostriction  of  the  water caused by 
hydrogen and chloride ion.  
 
Table-1: Values of the partial molar volume (V
o) and solute-solute interactions parameter (Sv) of Ciprofloxacin in various 
solvents at 208.15 K and 308.15K 
Solvents  Temperature(K)  V
o(cm
3mol
-1)  Sv (cm
3mol
-2 kg) 
Water 
298.15  273.216  500.141 
308.15  277.835  497.285 
HCl 
298.15  260.493  713.785 
308.15  269.973  499.114 
FeCl3.6H2O 
298.15  241.721  500.471 
308.15  246.362  498.957 
 
Table-2: Partial molar volumes and expansibilities of Ciprofloxacin studied in various solvents at 208.15 K and 308.15K 
Solvents  Temperature 
(K) 
E
o 
(cm
3mol
-1 K
-1)  (K
-110 
-3) 
Water 
298.15 
0.46 
1.683 
308.15  1.655 
HCl 
298.15 
0.37 
1.420 
308.15  1.370 
FeCl3.6H2O 
298.15 
0.47 
1.944 
308.15  1.907 
 
Table-3: Partial  molar transfer volume Vtr of ciprofloxacin in water and 0.05 mol/Kg HCl and water and 0.05 mol/Kg FeCl3 
solution 
Temperature  V
o (in water)  V
o (in aq. HCl)  V
o (in aq. FeCl3)  Vtr 
(cm
3 mol
-1) 
298.15  273.216  260.493  -  12.723 
308.15  277.835  269.973  -  7.862 
298.15  273.216  -  241.721  31.495 
308.15  277.835  -  246.362  31.473 
 
Partial molar expansibilities E
o, can be calculated using equation 2. E
o values obtained in this manner are shown in 
Table 2. The positive values of E
0 indicate that the hydration shell of the solute molecules increases in volume with a 
change of the solvent due to increase in the water molecules and hence indicate the predominance of hydrophobic 
hydration over the electrostriction of water molecules around the solute molecules. Jamal et al, 2011 
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The compound studied in this work is a flouroquinolone antibiotic which exhibits minimal side effects and has broad 
antimicrobial spectrum, is being used frequently to treat various infections
24. Fig-1 shows that an important structural 
feature of these compounds is the presence of hydrophobic and hydrophilic domains. The hydrophobicity of these 
compounds may well play a crucial role in the resulting drug reaction. It can be argued that the hydrophobic force 
supplements the structure-activity relationship in that these molecules tend to bind in a site-specific manner.  The 
hydrophilic and hydrophobic parts of the drug match with the specific counter sites on the membrane. The hydrophilic 
part of the drug molecule being anchored to the polar head group of the lipid chain (or at some suitable site on the 
imbedded  protein),  pushes  the  hydrophobic  tail  into  the  bilayer  grease.  The  decrease  of  the  bioavailability  of 
ciprofloxacin due to interactions with drugs or food containing metal ions is known for a long time
25, 26. A marked 
rank order correlation between the extent of ciprofloxacin coordination with various metal cations and the reduction in 
ciprofloxacin  oral  bioavailability  was  observed.  Thus,  the reduction  of  bioavailability  is  somehow  related  to the 
formation  of  complexes  between  ciprofloxacin  and  metal  ions
27.  The  complexed  species  is  different  from  the 
uncomplexed drug in size, geometry and charge. These factors could hinder the passive diffusion of ciprofloxacin 
through the cell membranes
27, 28. Thus the partial molar volume, V
0, of ciprofloxacin values (Table 1) in FeCl3 solution 
was found to be decreased as compared with water and HCl which may be due to the complex formation. 
 
 
Fig-1: 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid 
 
 
Fig-2: Molality and Apparent molar volume (V ) plot for Ciprofloxacin in H2O at 298.15 K and 308.15 K 
 
 
Fig-3: Molality and Apparent molar volume (V ) plot for Ciprofloxacin in HCl at 298.15 K and 308.15 K 
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Fig-4: Molality and Apparent molar volume (V ) plot for Ciprofloxacin in FeCl3.6H2O at 298.15 K and 308.15 K 
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